The availability of an oral option represents a meaningful change for individuals seeking medically supported weight management without injectable delivery
Tesamorelin adds preferential visceral fat targeting to the equation
Some people may experience a bad or funny taste in their mouth while using Wegovy
for example, a 5 mg dose was associated with a 20% decrease in body weight, and a 2.5 mg regimen showed a 15% reduction in HbA1c in published analyses
Part Ten: PBM and Payer Dynamics in the Post-Expiry Market Formulary Mechanics Pharmacy benefit managers (PBMs) are the most powerful actors in determining how quickly branded drugs lose market share after patent expiry
Current mainstay interventions, including intensive lifestyle modification and bariatric surgery, demonstrate suboptimal and often unsustainable long-term efficacy in this genetically defined population, highlighting a critical unmet need for effective, accessible, and durable pharmacological strategies